Status:
COMPLETED
Glutamine Supplementation and Short-term Mortality in Covid-19
Lead Sponsor:
Assiut University
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The aim of this study is to investigate the effect of parenteral L-Glutamine supplementation added to enteral nutrition on short-term ICU mortality (7 days) in Covid-19 diseased patients.
Detailed Description
A written informed consent will be taken from the patients or their relatives. Patients with diagnosis of covid-19 with enteral nutrition will be enrolled. Patients will be randomly assigned to receiv...
Eligibility Criteria
Inclusion
- Diagnosis of covid-19 diseased patients admitted to the ICU with enteral nutrition.
Exclusion
- Renal failure (creatinine \>180 mmol/l)
- Hepatic failure (bilirubin \>40 mmol/l, alanine aminotransferase \>100 U/l and aspartate aminotransferase \>100 U/l)
- Severe neutropenia (\<500 cells/mm3)
- Patients receiving cytotoxic, radiation and/or steroid therapy
- Hemodynamic instability
Key Trial Info
Start Date :
May 30 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04909905
Start Date
May 30 2021
End Date
October 30 2021
Last Update
November 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Omar Soliman
Asyut, Assuit, Egypt, Assuit universi